
SCI — Investor Relations & Filings
SCI Pharmtech, Inc. specializes in the research, development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and specialty chemicals. Established in 1987 and originally founded by the Swiss Siegfried Group, the company provides high-quality chemical solutions and custom manufacturing services to leading global pharmaceutical corporations across Europe, North America, and Japan. Its core operations encompass advanced chemical synthesis, process optimization, and large-scale production within GMP-compliant facilities. With a robust R&D infrastructure including specialized laboratories and pilot plants, the company delivers technical excellence in complex chemical processing. SCI Pharmtech maintains a strong focus on quality assurance and international regulatory compliance, positioning itself as a reliable partner for the global healthcare and life sciences sectors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 公告本公司115年股東常會重要決議事項。 | 2026-05-22 | Chinese | |
| 公告本公司115年第一季財務合併報告董事會預計召開 日期為115年5月7日。 | 2026-04-29 | Chinese | |
| 113年8月變更登記 | 2026-04-21 | Chinese | |
| 公司基本資料 | 2026-04-21 | Chinese | |
| 115年年報及股東會資料 — 2026_4119_20260522F13.pdf | 2026-04-17 | Chinese | |
| 115年年報及股東會資料 — 2026_4119_20260522F17.pdf | 2026-04-17 | Chinese |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46764743 | 公告本公司115年股東常會重要決議事項。 | 2026-05-22 | Chinese | ||
| 38492599 | 公告本公司115年第一季財務合併報告董事會預計召開 日期為115年5月7日。 | 2026-04-29 | Chinese | ||
| 34696999 | 113年8月變更登記 | 2026-04-21 | Chinese | ||
| 34697023 | 公司基本資料 | 2026-04-21 | Chinese | ||
| 34655412 | 115年年報及股東會資料 — 2026_4119_20260522F13.pdf | 2026-04-17 | Chinese | ||
| 34655409 | 115年年報及股東會資料 — 2026_4119_20260522F17.pdf | 2026-04-17 | Chinese | ||
| 34655407 | 115年年報及股東會資料 — 2026_4119_20260522F02.pdf | 2026-04-17 | Chinese | ||
| 34655403 | 115年年報及股東會資料 — 2026_4119_20260522F01.pdf | 2026-04-17 | Chinese | ||
| 34644347 | 114年第4季財務報告書 — 202504_4119_AIC.pdf | 2026-04-16 | English | ||
| 34644337 | 114年第4季財務報告書 — 202504_4119_AIA.pdf | 2026-04-16 | English | ||
| 34644329 | 114年第4季財務報告書 — 202503_4119_AI1.pdf | 2026-04-16 | Chinese | ||
| 34644293 | 114年第4季財務報告書 — 202502_4119_AIA.pdf | 2026-04-16 | English | ||
| 33874334 | 115年03月內部人持股異動(事後) | 2026-04-09 | Chinese | ||
| 33874333 | 115年03月董事會成員及持股 | 2026-04-09 | Chinese | ||
| 33799524 | 115年3月背書保證與資金貸與 | 2026-04-08 | Chinese | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Biocon Ltd.
Develops biosimilars and novel biologics for diabetes, onco…
|
BIOCON | IN | Manufacturing |
|
BIOCRYST PHARMACEUTICALS INC
Develops novel medicines for patients with rare and serious…
|
BCRX | US | Manufacturing |
|
Biocure Technology Inc.
Develops and commercializes advanced biological medicines, …
|
CURE.X | CA | Manufacturing |
|
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.
Develops novel antibody-based drugs and provides integrated…
|
2315 | HK | Manufacturing |
|
Biodexa Pharmaceuticals Plc
Clinical-stage biopharma developing treatments for rare dis…
|
BDRX | GB | Manufacturing |
|
BioDlink International Company Limited
Integrated biopharmaceutical CDMO specializing in ADC platf…
|
1875 | HK | Manufacturing |
|
BioEnvelop Technologies Corporation
Developed rapidly dissolving edible film strips for nutrace…
|
BIE | CA | Manufacturing |
|
Biofarm S.A.
A pharmaceutical company that manufactures and markets medi…
|
BIO | RO | Manufacturing |
|
BIO-FD&C CO.,LTD.
Develops active ingredients for cosmetics and pharma using …
|
251120 | KR | Manufacturing |
|
Biofil Chemicals & Pharmaceuticals
Produces pharmaceutical formulations, bulk drugs, and plast…
|
BIOFILCHEM | IN | Manufacturing |
SCI via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/52383/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=52383 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=52383 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=52383 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 52383}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SCI (id: 52383)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.